BiotechTube
Rithem Life Sciences

Rithem Life Sciences

San Diego, United States· Est.
rithemls.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.8M

Overview

Rithem Life Sciences is a private, commercial-stage medical device company founded in 2020 and headquartered in San Diego, CA (with a corporate address in Wilmington, DE). It addresses the massive unmet need in out-of-hospital cardiac arrest by developing and selling direct-to-consumer devices designed for ease of use in home settings. The company's product portfolio, consisting of the ResQR CPR aid and the upcoming JoltzAED, targets the significant mortality gap caused by delays in CPR and defibrillation, positioning Rithem in the public-access emergency response market.

Cardiovascular

Technology Platform

Ergonomic hardware platform for guided emergency cardiac response. Focuses on user-friendly design, audio/visual prompts for CPR, and miniaturization of AED technology for at-home use.

Funding History

1
Total raised:$3.8M
Seed$3.8M

Opportunities

The massive, underpenetrated residential market for AEDs represents a multi-billion dollar opportunity, driven by the high incidence of at-home cardiac arrests.
Growing public awareness of cardiac arrest and the limitations of EMS response times creates a favorable environment for consumer adoption of life-saving devices for the home.

Risk Factors

Significant regulatory and product liability risks are inherent in life-critical medical devices.
Market adoption is challenged by the need to convince consumers to purchase a device for a low-probability event.
The company faces competition from large, established AED manufacturers with greater resources.

Competitive Landscape

Rithem competes in the public-access defibrillator and CPR aid markets against large, established players like Philips, ZOLL (a Stryker company), and Physio-Control. Its strategy is to differentiate through consumer-focused design, affordability, and a direct-to-consumer sales model, targeting the home rather than traditional public spaces.

More companies in Digital Health & Biotech SaaS →More companies in United States →